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tients is suitability for surgery. I am unclear
on a few points in the article, however, and
have some questions for the authors.
This landmark work began just after
introduction of the Fontan principle. Is this
why initial modifications were done in a
majority of patients? Or is there another
reason? Do you continue to do these mod-
ifications today? If so, for what indications
and why? The issue of superiority of 1
modification over others in long-term re-
sults is far from resolved. For budding car-
diac surgeons like me, which type of mod-
ification do you recommend for
hemodynamically adequate adult patients?
In other words, what should govern my
choice of modification in different sets of
patients?
The fenestrated Fontan modification has
widened the horizon of univentricular re-
pair. You have elaborately described your
point. Do you feel in spite of anticoagula-
tion the incidence of thromboembolic and
other side effects or complications out-
weighs the benefit of fenestration in de-
creasing the morbidity of procedure, which
has been vigorously tested? Does the age of
the patients also affect the decision to fe-
nestrate? If yes, in what way?2,3
What is your policy regarding 1-stage
or 2-stage procedure? For example, do you
perform superior cavopulmonary first and
then complete the Fontan as a separate pro-
cedure, especially for patients without pal-
liation or with systemic to pulmonary ar-
tery shunts or pulmonary artery banding? Is
the principle of gradual volume unloading
of the ventricle different in adults than chil-
dren?
Once again, I thank the authors for this
outstanding article.
Manoj Purohit
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Reply to the Editor:
In the setting of single ventricle physiol-
ogy, the common and accepted practice is
to proceed with the Fontan procedure at 2
to 4 years of age in the majority of circum-
stances. In developing countries, the oppor-
tunity for staged palliation with eventual
Fontan procedure in young children is less
common. Some children may have under-
gone a palliative operation with a systemic-
to-pulmonary artery shunt or cavopulmo-
nary shunt during early childhood but were
lost to follow-up or never had the opportu-
nity for the completion Fontan procedure.
Consequently, there are potentially a
greater number of older patients who may
be candidates for the Fontan procedure in
developing countries.
In our experience with more than 1000
patients, surgical modifications to the Fon-
tan procedure have evolved over the last 3
decades in an effort to avoid complications
occurring late after operation. Currently,
the technique of the Fontan procedure that
is applied in our patients includes the total
cavopulmonary connection with an extra-
cardiac conduit or intra-atrial conduit. We
believe this technique will minimize the
incidence of late atrial arrhythmias.
To reduce the risk of thromboembo-
lism, we eliminate blind stumps (eg, seg-
ment above the pulmonary valve) and blind
intracardiac chambers (eg, vestigial right
ventricle in tricuspid atresia via the ventric-
ular septal defect) that are exposed to the
systemic circulation. This is accomplished
by patch or suture closure of the pulmonary
valve annulus or closure of the ventricular
septal defect.
When significant risk factors for early
mortality are present prior to the Fontan
procedure, such as severe atrioventricular
valve regurgitation, severe pulmonary ar-
tery abnormalities, or severe subaortic ste-
nosis, we would proceed with a staged sur-
gical approach that corrects these
abnormalities prior to the completion Fon-
tan procedure. This would include repair or
replacement of the atrioventricular valve,
relief of pulmonary artery stenosis or dis-
tortion, and relief of subaortic stenosis (re-
section or Damus-Stansel-Kaye anastomo-
sis). A concomitant bidirectional
cavopulmonary anastomosis is also com-
monly performed at this time. The comple-
tion of the Fontan procedure would then be
performed at a subsequent operation. Mi-
nor intracardiac or pulmonary artery abnor-
malities are corrected at the time of the
Fontan procedure. In the absence of risk
factors, we do not believe it is necessary to
perform a bidirectional cavopulmonary
shunt prior to the Fontan procedure.
We have used the fenestration selec-
tively at the time of the Fontan procedure.
Although we attempt to correct major ab-
normalities during the course of a staged
surgical approach in an effort to reduce
operative risk, some reversible risk factors
for early or late mortality may still be
present. These may include elevated preop-
erative pulmonary artery pressure, revers-
ible ventricular dysfunction, increased ven-
tricular mass, or uncorrected pulmonary
artery abnormalities. Fenestration has also
been used in patients with predominant
right ventricular morphology.
The role of warfarin anticoagulation af-
ter the Fontan procedure has been contro-
versial. In general, we tend to anticoagulate
most adult patients, particularly those with
a fenestration or residual intracardiac
shunt, history of arrhythmias, intracardiac
thrombus, slow circulation, and venous
varices. In children and young adult pa-
tients, we may substitute aspirin as an al-
ternative to warfarin anticoagulation.
Joseph A. Dearani, MD
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Mitral valve surgery with extensive
calcification of the annulus
To the Editor:
Feindel and coauthors1 report results in a
challenging set of patients, those with mi-
tral annular calcification (MAC) causing
mitral regurgitation. Several alternative
techniques to avoid excising the calcified
bar all have disadvantages. Displacing the
prosthetic sewing line into the left atrium
(with or without a prosthetic cuff) subjects
the left atrium to high ventricular pressure.
Sewing to the mitral leaflets central to the
calcified bar requires sewing to fragile tis-
sue and downsizing the valve. Sewing to
the calcified bar usually leads to dehis-
cence, and trying to pass the sutures around
the bar jeopardizes the circumflex coronary
artery.
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An ultrasonic decalcification tool eas-
ily pulverizes and extracts the MAC.2,3
This device spares soft tissue, and hence
the circumflex coronary artery is pre-
served. Because the left ventricle, left
atrium, and mitral leaflet(s) are largely
disconnected, reconstruction may require
an annular patch as Feindel and cowork-
ers1 describe for valve repair. For valve
replacement, sutures passed from left
atrium, to left ventricle, around the resid-
ual mitral leaflet, and through the pros-
thetic annulus suffice to reconstitute the
annulus.2 Because the vital structures of
the atrioventricular (AV) groove fall pos-
teriorly, the visualization of the top of the
left ventricle where it abuts the annulus
allows the placement of sutures deep into
the muscle without injuring the AV
groove vessels.
I have used this technique in 38 pa-
tients, 19 of whose results were previously
reported.3 The mean age was 73 years
(range 56-84 years), and the mean circum-
ferential calcification requiring debride-
ment was 157° (range 45°-330°). Six pa-
tients had mitral repairs; 32 had
replacements (17 St Jude Medical [St Jude
Medical, Inc, St Paul, Minn], 15 porcine). At
the time of operation, 2 patients were noted to
have a posterior AV groove hematoma: 1
resolved without treatment, and 1 patient died
1 month postoperatively of multiorgan failure
but the hematoma could not be shown to be a
contributing factor. Four other patients died.
None of the deaths were related to the annu-
lar decalcification. No patient developed a
paravalvular leak. No patient suffered injury
to the circumflex coronary artery or the cor-
onary sinus.
This technique may be underappreci-
ated and underused. I have been frus-
trated by attempts to excise the calcified
bar as described by Carpentier and col-
leagues.4 It has seemed to be sufficiently
imbedded in the annulus and adjacent
structures that I feared damaging the cir-
cumflex coronary artery or great coronary
vein/coronary sinus. The very gentle de-
bridement rendered by the ultrasonic as-
pirator makes it a valuable tool that I
continue to use and recommend. Its abil-
ity to pulverize selectively the hard cal-
cified tissue without injuring soft tissue
permits safely attaining complete pliabil-
ity in the annular region. As Feindel and
colleagues1 made clear, a major concern
of any procedure to remove the MAC is
the potential of AV separation, and con-
siderable care must be taken in the recon-
stitution of this area.
Thomas J. Vander Salm, MD
Massachusetts General Hospital
and North Shore Medical Center
Salem, MA 01970
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Reply to the Editor:
I would like to thank Dr Vander Salm for
bringing this unique method for manag-
ing extensive mitral annular calcification
to our attention. Although we have no
experience with the use of ultrasound de-
calcification, it appears to be a very use-
ful method in these cases. Surgeons who
have such ultrasound devices available to
them should consider using them to re-
move the calcium bar. Any method that
reduces the risk of operating on these
patients is welcomed. There are good rea-
sons why some have referred to the cal-
cium bar in the mitral annulus as the “Bar
of Death.”
Chris Feindel, MD, CM
The Munk Cardiovascular Centre, University
Health Network and the University of Toronto,
Toronto, Ontario, Canada
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Early failure of bovine jugular vein
conduits
To the Editor:
We read with great interest the article by
Boudjemline and colleagues1 recently pub-
lished in The Journal of Thoracic and Car-
diovascular Surgery. They describe the early
results of the bovine jugular vein conduits
placed in the right ventricular outflow tract.
The event-free survival curve was less than
70% at only 3 months after surgery. There
was 1 late death related to the conduit, 1
episode of thrombus formation that required
heparin therapy, and another 3 patients re-
quired conduit replacement at a mean interval
of 4.3 months after the initial operation. An
interesting finding was an aneurysmal dila-
tion of the distal portion of the conduit.
Our experience has been similar to that
of the authors. Three patients required con-
duit replacement at 16, 18, and 25 months
after the initial operation. All patients had a
significant gradient between the right ven-
tricle and the pulmonary artery branches,
mainly the left main pulmonary branch; an
aneurysmal dilation of the distal conduit
occurred in 2 patients and varying degrees
of pulmonary insufficiency occurred in all.
Conduit diameters were 12 mm in 2 pa-
tients and 14 mm in the other patient. All
patients were on antiaggregant therapy,
which is our standard management proto-
col for grafts.
Findings at surgery were disappearance
of the conduit valve, presence of a huge
aneurysmal dilation of the conduit in 2
cases, and extensive fibrosis at the conduit-
pulmonary artery anastomotic line in all.
This particular finding is of extreme impor-
tance, since our patients, as well as 2 pa-
tients in Boudjemline’s article, have persis-
tent residual pulmonary artery stenosis,
despite extensive reconstruction during
conduit replacement.
The bovine jugular vein conduit prom-
ised to be the conduit of choice for use in
neonates and infants due to its excellent
handling properties, but these early and
midterm complications should raise a note
of caution on its use.
Claudio Zavanella, MD
Francisco Portela, MD
Pediatric Cardiac Surgery Section, Complejo
Hospitalario Universitario Juan Canalejo,
A Corun˜a, Spain
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